Protocol Ledger

NCT04787744 · Phase II/III · ACTIVE NOT RECRUITING

Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer

Interventional Phase II/III clinical trial protocol NCT04787744 sponsored by VA Office of Research and Development in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2021-07-01 Enrollment: 378 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT04787744
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)378 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)0 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04787744
Protocol FieldVerified Registry Value
NCT IdentifierNCT04787744
Consolidated Lead SponsorVA Office of Research and Development
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase II/III
Overall Recruitment StatusACTIVE NOT RECRUITING
Registered Enrollment378 participants (ACTUAL)
Registered Start Date2021-07-01
WhyStopped ClassificationNot Stopped

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI